Journals / Atatürk Üniversitesi Diş Hekimliği Fakültesi Dergisi / 2021 / Cilt: 31 - Sayı: 1

TREATMENT OF BRUXISM PATIENTS WHO USING SELECTIVE SEROTONIN REUPTAKE INHIBITORS

SELEKTİF SEROTONİN GERİALIM İNHİBİTÖRÜ KULLANAN BRUKSİZM HASTALARININ TEDAVİSİ

Pages
83–87
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In binary comparisons; dependent, independent t-tests, Wilcoxon and Mann-Whitney U tests were used and the results of all analyzes were evaluated as significance p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Bruxism is repetitive chewing muscle activities characterized by uncontrolled tightening or grinding of teeth.
📊
Key Findings & Data:Material and Methods: A total of 22 patients who were diagnosed with bruxism and take SSRI-AD were included in the study.
💡
Conclusion & Impact:In binary comparisons; dependent, independent t-tests, Wilcoxon and Mann-Whitney U tests were used and the results of all analyzes were evaluated as significance p
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: Bruxism is repetitive chewing muscle activities characterized by uncontrolled tightening or grinding of teeth. There are case reports that Selective Serotonin Reuptake Inhibitor group antidepressants (SSRI-AD) cause bruxism. The aim of this study was to investigate whether patients using SSRI-AD with bruxism will be able to treat the bruxism by discontinuing the medication. Material and Methods: A total of 22 patients who were diagnosed with bruxism and take SSRI-AD were included in the study. The visual analog scale was used to determine the degree of pain at the palpation of the masticatory muscles and to what extent the complaint of bruxism affected the quality of life. In addition, short-form 12 (SF-12) questionnaire, which is a medical outcome evaluation study, was applied. The drug was discontinued and the measurements were repeated 6 weeks after discontinuation. Descriptive statistical methods (mean, standard deviation, minimum, maximum) were used in the evaluation of statistical data. In binary comparisons; dependent, independent t-tests, Wilcoxon and Mann-Whitney U tests were used and the results of all analyzes were evaluated as significance p

Özet

Amaç: Bruksizm; dişlerin kontrolsüz bir şekilde sıkılması veya gıcırdatılması ile karakterize tekrarlayan çiğneme kasaktiviteleridir. Selektif Serotonin Gerialım İnhibitörü grubu antidepresanların (SSRI-AD) bruksizme yol açtığına yönelik raporlarvardır. Bu çalışmanın amacı, SSRI-AD kullanan ve bruksizmi olan hastaların ilaç kesilerek bruksizm tablosunun düzelipdüzelmeyeceğini araştırmaktır.Gereç ve Yöntem: Çalışma bruksizm tanısı konulan ve anamnezinde SSRI-AD kullandığı öğrenilen 22 hasta ile yapılmıştır.Çiğneme kaslarına yapılan palpasyonda hissettiği ağrı ve bruksizm şikayetinin yaşam kalitesini ne ölçüde etkilediği vizüel analogskala (VAS) ile ölçülmüştür. Ayrıca medikal sonuç değerlendirme çalışması olan kısa-form 12 (SF-12) anketi uygulanmıştır.Hastanın kullandığı ilaç kesilmiştir ve ilaç kesiminden 6 hafta sonra ölçümler tekrarlanmıştır. İstatistiksel verilerindeğerlendirilmesinde tanımlayıcı istatistiksel metotlar (ortalama, standart sapma, minimum, maksimum) kullanılmıştır. İkilikarşılaştırmalarda bağımlı-bağımsız t-testleri ile Wilcoxon ve Mann-Whitney U testleri kullanılmış ve tüm analizlerin sonuçlarıanlamlılık p

🔖

Cite This Article

ÜÇOK, C., YURTTUTAN, M. E. (2022). TREATMENT OF BRUXISM PATIENTS WHO USING SELECTIVE SEROTONIN REUPTAKE INHIBITORS. Atatürk Üniversitesi Diş Hekimliği Fakültesi Dergisi, Cilt: 31 - Sayı: 1, 83–87. https://ajindex.com/articles/451581

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Nayak DS. The management of temporomandibular disorder using occlusal splint therapy and biobehavioral therapy. J Adv Clin Res Insights [Internet] 2016;3:94-100
  2. Alajbeg IZ, Brakus RB, Brakus I. Comparison of amitriptyline with stabilization splint and placebo in chronic TMD patients: a pilot study. Acta stomatologica Croatica 2018;52:114
  3. Guarda-Nardini L, Manfredini D, Salamone M, Salmaso L, Tonello S, Ferronato G. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study. CRANIO® 2008;26:126-35
  4. McAuliffe P. Types of bruxism. J Ir Dent Assoc 2012;58:138-41
  5. Örsel S. Depresyonda tedavi: Genel ilkeler ve kullanılan antidepresan ilaçlar. Klinik Psikiyatri, Ek 2004;4:17-24
  6. Kern DM, Cepeda MS, Defalco F, Etropolski M. Treatment patterns and sequences of pharmacotherapy for patients diagnosed with depression in the United States: 2014 through 2019. BMC Psychiatry 2020;20:4
  7. Garrett AR, Hawley JS. SSRI-associated bruxism: A systematic review of published case reports. Neurol Clin Pract 2018;8:135-41
  8. Pintado MR, Anderson GC, DeLong R, Douglas WH. Variation in tooth wear in young adults over a twoyear period. J Prosthet Dent 1997;77:313-20
  9. Rajan R, Sun YM. Reevaluating antidepressant selection in patients with bruxism and temporomandibular joint disorder. J Psychiatr Pract 2017;23:173-9
  10. Gerber PE, Lynd LD. Selective serotonin-reuptake inhibitor-induced movement disorders. Ann Pharmacother1998;32:692-8
  11. Sabuncuoglu O, Ekinci O, Berkem M. Fluoxetineinduced sleep bruxism in an adolescent treated with buspirone: a case report. Spec Care Dentist 2009;29:215-7
  12. Stahl SM. Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects. J Affect Disord 1998;51:215-35
  13. Chen WH, Lu YC, Lui CC, Liu JS. A proposed mechanism for diurnal/nocturnal bruxism: hypersensitivity of presynaptic dopamine receptors in the frontal lobe. J Clin Neurosci 2005;12:161-3
  14. Falisi G, Rastelli C, Panti F, Maglione H, Quezada Arcega R. Psychotropic drugs and bruxism. Expert Opin Drug Saf 2014;13:1319-26
  15. Ellison JM, Stanziani P. SSRI-associated nocturnal bruxism in four patients. J Clin Psychiatry 1993; 54: 432-4
  16. Fitzgerald K, Healy D. Dystonias and dyskinesias of the jaw associated with the use of SSRIs. Human Psychopharmacology: Clin Experiment 1995; 10:215-9
  17. Milanlioglu A. Paroxetine-induced severe sleep brux